Patient-Formulary-2017
Total Page:16
File Type:pdf, Size:1020Kb
Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 04 05 2017 Formulary Title Section Annotation Status Rare paediatric conditions On Formulary Prescribing for children DTC officer decision CHARCOAL, ACTIVATED On Formulary Removal and elimination->Removal from the gastro-intestinal tract Removal and elimination->Removal from the gastro-intestinal Actidose-Aqua® Advance On Formulary tract->CHARCOAL, ACTIVATED Removal and elimination->Removal from the gastro-intestinal Carbomix® On Formulary tract->CHARCOAL, ACTIVATED Removal and elimination->Removal from the gastro-intestinal Charcodote® On Formulary tract->CHARCOAL, ACTIVATED ACETYLCYSTEINE On Formulary Specific drugs->Analgesics (non-opioid) Acetylcysteine On Formulary Specific drugs->Analgesics (non-opioid)->ACETYLCYSTEINE Parvolex® On Formulary Specific drugs->Analgesics (non-opioid)->ACETYLCYSTEINE NALOXONE HYDROCHLORIDE On Formulary Specific drugs->Analgesics (opioid) Naloxone On Formulary Specific drugs->Analgesics (opioid)->NALOXONE HYDROCHLORIDE Minijet® Naloxone On Formulary Specific drugs->Analgesics (opioid)->NALOXONE HYDROCHLORIDE DESFERRIOXAMINE MESILATE On Formulary Specific drugs->Iron salts DICOBALT EDETATE On Formulary Other poisons->Cyanides Dicobalt Edetate On Formulary Other poisons->Cyanides->DICOBALT EDETATE SODIUM THIOSULFATE On Formulary Other poisons->Cyanides Sodium Thiosulfate On Formulary Other poisons->Cyanides->SODIUM THIOSULFATE PRALIDOXIME CHLORIDE On Formulary Other poisons->Pesticides 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids ALUMINIUM HYDROXIDE On Formulary and simeticone->Aluminium- and magnesium-containing antacids 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids Co-magaldrox On Formulary and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids Maalox® On Formulary and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE->Co-magaldrox 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids MAGNESIUM TRISILICATE On Formulary and simeticone->Aluminium- and magnesium-containing antacids 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids Magnesium Trisilicate Mixture, BP On Formulary and simeticone->Aluminium- and magnesium-containing antacids->MAGNESIUM TRISILICATE 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids Infacol® Restricted during endoscopies as a surfactant only and simeticone->Simeticone alone 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound Peptac® On Formulary alginates and proprietary indigestion preparations->Alginate raft-forming oral suspensions 1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound Gaviscon Infant® Restricted alginates and proprietary indigestion preparations->Other compound Paediatrics alginate preparations 1.2 Antispasmodics and other drugs altering gut ATROPINE SULFATE Restricted Tablets for Myaesthenia gravis only motility->Antimuscarinics 1.2 Antispasmodics and other drugs altering gut Atropine On Formulary Tablets for Myaesthenia gravis only motility->Antimuscarinics->ATROPINE SULFATE 1.2 Antispasmodics and other drugs altering gut HYOSCINE BUTYLBROMIDE On Formulary motility->Antimuscarinics 1.2 Antispasmodics and other drugs altering gut Buscopan® On Formulary motility->Antimuscarinics->HYOSCINE BUTYLBROMIDE 1.2 Antispasmodics and other drugs altering gut motility->Other MEBEVERINE HYDROCHLORIDE On Formulary not MR preparations antispasmodics 1.2 Antispasmodics and other drugs altering gut motility->Other Mebeverine Hydrochloride On Formulary antispasmodics->MEBEVERINE HYDROCHLORIDE 1.2 Antispasmodics and other drugs altering gut motility->Other PEPPERMINT OIL On Formulary antispasmodics 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor the dispersible tablets are not stocked RANITIDINE On Formulary antagonists DTC officer decision 1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor Ranitidine On Formulary antagonists->RANITIDINE 1.3 Antisecretory drugs and mucosal protectants->1.3.4 Prostaglandin Consultant Obstetricians only as per RCOG protocol for post partum haemorrhage MISOPROSTOL Restricted analogues Not for GI use 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump LANSOPRAZOLE On Formulary Capsules only. See the entry for Zoton® for restrictions on orodispersible tablets inhibitors 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Lansoprazole On Formulary inhibitors->LANSOPRAZOLE 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Zoton® Restricted FasTab® for swallowing difficulties only inhibitors->LANSOPRAZOLE Second line - CAUTION: Interactions! 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump OMEPRAZOLE Restricted inhibitors MUPS® are restricted to paediatrics only PPI choices Lansoprazole is the preferred proton pump inhibitor and omeprazole second-line 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Omeprazole On Formulary Second line - caution Interactions! inhibitors->OMEPRAZOLE 1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump Losec® Restricted MUPS® - Paediatrics only inhibitors->OMEPRAZOLE CODEINE PHOSPHATE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs Gastroenterology and oncology for chronic diarrhoea and stoma care LOPERAMIDE HYDROCHLORIDE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs N.B. the melts are non-formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE Loperamide On Formulary HYDROCHLORIDE 1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE Imodium® On Formulary HYDROCHLORIDE MORPHINE On Formulary 1.4 Acute diarrhoea->1.4.2 Antimotility drugs BALSALAZIDE SODIUM Restricted 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Patients intolerant of Mesalazine or Sulfasalazine 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->BALSALAZIDE Colazide® Restricted Patients intolerant of Mesalazine or Sulfasalazine SODIUM MESALAZINE On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Asacol® Restricted 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE For patients already taking this brand Asacol® MR Restricted 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE For patients already taking this brand Octasa® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Pentasa® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Salofalk® On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE SULFASALAZINE On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates Sulfasalazine On Formulary 1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE BUDESONIDE Restricted 1.5 Chronic bowel disorders->1.5.2 Corticosteroids Gastroenterology PREDNISOLONE On Formulary 1.5 Chronic bowel disorders->1.5.2 Corticosteroids 1.5 Chronic bowel disorders->1.5.2 Predsol® On Formulary Corticosteroids->PREDNISOLONE->Rectal preparations 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune AZATHIOPRINE Restricted for oncology treatment and for immunological therapy by those experienced response This will be available in the Trust for patients who meet the NICE criteriaif a clinician requests its use. 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune ADALIMUMAB Restricted ForSandwell and West Birmingham CCG patientsaBlueteq formwill have to be completed for each patient. response->Cytokine modulators For all other patients please completethis pro forma. This will be available in the Trust for patients who meet the NICE criteriaif a clinician requests its use. 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune INFLIXIMAB Restricted ForSandwell and West Birmingham CCG patientsaBlueteq formwill have to be completed for each patient. response->Cytokine modulators For all other patients please completethis pro forma. 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune Preparations Restricted In accordance with NICE guidelines only response->Cytokine modulators->INFLIXIMAB ForSandwell and West Birmingham CCG patientsaBlueteq formwill have to be completed for each patient. 1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune VEDOLIZUMAB NICE-approved response->Vedolizumab For all other patients please completethis pro forma. ISPAGHULA HUSK On Formulary 1.6 Laxatives->1.6.1 Bulk-forming laxatives use cheapest preparation available METHYLCELLULOSE On Formulary 1.6 Laxatives->1.6.1 Bulk-forming laxatives DANTRON Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives Palliative care - n.b. only co-danthramer syrup and co-danthrusate capsules are stocked With poloxamer ‘188’ (as Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON palliative care - Syrup only co-danthramer) 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON->With poloxamer Palliative care Co-danthramer Restricted �188� (as co-danthramer) DTC officer decision With docusate sodium (as Restricted 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON Palliative care - capsules only co-danthrusate) 1.6 Laxatives->1.6.2 Stimulant laxatives->DANTRON->With docusate Co-danthrusate Restricted Palliative care sodium (as co-danthrusate) the adult strength solution is NOT stocked DOCUSATE SODIUM On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives DTC officer decision GLYCEROL On Formulary 1.6 Laxatives->1.6.2 Stimulant laxatives Glycerol